Tyra Biosciences, Inc.
Price Action
Technical Summary
EMERGING TRENDTyra Biosciences, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 93), indicating clear outperformance against the broad market. Earnings contraction of 33% provides fundamental context to the price action. Investors should exercise caution due to high volatility (62% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $35.24 | -6.63% | BELOW |
| 50 SMA | $35.84 | -8.21% | BELOW |
| 100 SMA | $32.27 | +1.95% | ABOVE |
| 150 SMA | $27.13 | +21.26% | ABOVE |
| 200 SMA | $23.29 | +41.24% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TYRA in an uptrend right now?
TYRA has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is TYRA overbought or oversold?
TYRA's RSI (14) is 43. The stock is in neutral territory, neither overbought nor oversold.
Is TYRA outperforming the market?
TYRA has a Relative Strength (RS) Rating of 93 out of 99. Yes, TYRA is a market leader, outperforming 93% of all stocks over the past 12 months.
Where is TYRA in its 52-week range?
TYRA is trading at $32.90, which is 81% of its 52-week high ($40.65) and 76% above its 52-week low ($8.75).
How volatile is TYRA?
TYRA has a Beta of 0.75 and 52-week volatility of 62%. It's less volatile than the S&P 500 - generally more stable.